心血管病学进展
心血管病學進展
심혈관병학진전
ADVANCES IN CARDIOVASCULAR DISEASES
2015年
3期
312-314,315
,共4页
金海姣(综述)%倪兆慧(审校)
金海姣(綜述)%倪兆慧(審校)
금해교(종술)%예조혜(심교)
腹膜透析%难治性充血性心力衰竭%利尿剂抵抗
腹膜透析%難治性充血性心力衰竭%利尿劑牴抗
복막투석%난치성충혈성심력쇠갈%이뇨제저항
peritoneal dialysis%refractory congestive heart failure%resistance to diuretics
充血性心力衰竭在世界范围内发病率高、预后差、对生活质量影响大。目前的治疗方法主要包括限制水钠摄入、应用利尿剂、肾素-血管紧张素-醛固酮系统阻滞剂等,但上述方法控制容量作用有限,且常导致有效循环容量下降,肾脏灌注不足,损害肾功能,进而加重循环系统损害。应用腹膜透析治疗难治性充血性心力衰竭能够平稳而有效地改善液体潴留,避免心排血量下降,同时纠正电解质紊乱和肾功能不全。现对腹膜透析治疗难治性充血性心力衰竭的研究进展做一综述。
充血性心力衰竭在世界範圍內髮病率高、預後差、對生活質量影響大。目前的治療方法主要包括限製水鈉攝入、應用利尿劑、腎素-血管緊張素-醛固酮繫統阻滯劑等,但上述方法控製容量作用有限,且常導緻有效循環容量下降,腎髒灌註不足,損害腎功能,進而加重循環繫統損害。應用腹膜透析治療難治性充血性心力衰竭能夠平穩而有效地改善液體潴留,避免心排血量下降,同時糾正電解質紊亂和腎功能不全。現對腹膜透析治療難治性充血性心力衰竭的研究進展做一綜述。
충혈성심력쇠갈재세계범위내발병솔고、예후차、대생활질량영향대。목전적치료방법주요포괄한제수납섭입、응용이뇨제、신소-혈관긴장소-철고동계통조체제등,단상술방법공제용량작용유한,차상도치유효순배용량하강,신장관주불족,손해신공능,진이가중순배계통손해。응용복막투석치료난치성충혈성심력쇠갈능구평은이유효지개선액체저류,피면심배혈량하강,동시규정전해질문란화신공능불전。현대복막투석치료난치성충혈성심력쇠갈적연구진전주일종술。
Worldwide prevalence of congestive heart failure( CHF) remains high.Current treatment of CHF consists of the restriction of salt and fluid, and diuretics and renin-angiotensin-aldosterone system blockers.However, these treatments may result in a drop of effec-tive circulating volume, and insufficient renal perfusion, which in turn trigger aggravated damage to the circulatory system.These treatments also play a limited role in volume control in refractory congestive heart failure( RCHF).Specifically for RCHF, peritoneal dialysis might be an effective treatment strategy based on the slow but effective ultrafiltration to relieve fluid overload without reducing cardiac output, as well as correction of electrolyte imbalance and protection of renal function.In this review, the development of peritoneal dialysis as a treatment for RCHF is discussed.